InspireMD, Inc. NSPR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.48M | -51.31M | -48.79M | -46.20M | -41.38M |
| Total Depreciation and Amortization | 578.00K | 527.00K | 476.00K | 408.00K | 350.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.35M | 11.54M | 12.10M | 11.92M | 10.44M |
| Change in Net Operating Assets | 346.00K | 591.00K | 1.11M | 1.36M | 1.02M |
| Cash from Operations | -41.21M | -38.65M | -35.10M | -32.51M | -29.58M |
| Capital Expenditure | -1.25M | -1.50M | -1.66M | -1.58M | -1.67M |
| Sale of Property, Plant, and Equipment | 15.00K | 15.00K | 15.00K | 15.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.92M | -16.00M | -28.91M | 24.38M | 11.01M |
| Cash from Investing | -8.15M | -17.48M | -30.56M | 22.82M | 9.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.05M | 58.19M | 58.72M | 60.36M | 4.31M |
| Repurchase of Common Stock | -3.15M | -3.15M | -3.15M | -- | -964.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.00K | 22.00K | 0.00 | -3.23M | -103.00K |
| Cash from Financing | 52.93M | 55.06M | 55.57M | 57.13M | 3.24M |
| Foreign Exchange rate Adjustments | 76.00K | 47.00K | 117.00K | 144.00K | 116.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.64M | -1.02M | -9.98M | 47.59M | -16.88M |